We focused on 14 lncRNAs known to be either oncogenic (CTBP1AS, MALAT1, UCA1), tumor-suppressive (GAS5, MEG3, TP53COR1), and with prognostic (H19, SNHG16, TUG1, XIST, HOTAIR BLACAT1) or therapeutic relevance (CBR3AS1, SRA1)12–28. This evidence concerns the gene MALAT1 and neoplasm.